David G. Workman

Protection from neurodegeneration in the 6-hydroxydopamine (6-OHDA) model of Parkinson's with novel 1-hydroxypyridin-2-one metal chelators

David G. Workman, Andrew Tsatsanis, Frank W. Lewis et al. · Metallomics · 2015 · 40 citations · Full text

Medicine, Neuroscience, Pharmacology +17

Synthesis of novel Iron(III) chelators based on triaza macrocycle backbone and 1-hydroxy-2(H)-pyridin-2-one coordinating groups and their evaluation as antimicrobial agents

David G. Workman, Michael Hunter, Lynn G. Dover et al. · Journal of Inorganic Biochemistry · 2016 · 25 citations · Full text

Pharmacy, Chemistry, Medicinal Chemistry +14

Limiting the level of tertiary amines on polyamines leads to biocompatible nucleic acid vectors

Margarida Isabel Simão Carlos, Kai Zheng, Natalie Garrett et al. · International Journal of Pharmaceutics · 2017 · 21 citations

Life Sciences, Biochemistry, Biotechnology +9

The influence of linkages between 1-hydroxy-2(1H)-pyridinone coordinating groups and a tris(2-aminoethyl)amine core in a novel series of synthetic hexadentate iron(III) chelators on antimicrobial activity

David G. Workman, Michael Hunter, Shuning Wang et al. · Bioorganic Chemistry · 2019 · 15 citations

Natural Sciences, Chemistry, Medicinal Chemistry +9